ClinicalTrials.govpublic full text
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
acute myeloid leukemia, infantile leukemia (both aml and all), myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasms, biphenotypic leukemia, sorafenib, cytarabine, clofarabine, acute promyelocytic leukemia, acute lymphoblastic leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 812791
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.